All News

CAR-T Cell Therapy May Have ‘Big Future’ in Relapsed/ Refractory Multiple Myeloma

March 17th 2022

Durable and deep responses occurred in patients with multiple myeloma after use of a particular CAR-T cell therapy

Clinical Trial Testing Novel Treatment With Standard-of-Care Chemotherapy in Patients With Pancreatic Cancer Expands to New Location

March 16th 2022

Four sites across the United States are enrolling patients with locally advanced or metastatic pancreatic cancer to see if a novel drug combined with standard-of-care chemotherapy bests chemotherapy alone in survival outcomes and responses to treatment.

Opdivo-Based Combo Continues to Improve Survival Outcomes in Previously Untreated Patients With Metastatic or Unresectable Melanoma

March 16th 2022

The findings, according to the study’s lead author, justify the use of Opdivo plus relatlimab as a new treatment option for patients with advanced melanoma, a form of skin cancer.

Patients With Cancer in Ukraine Are Fighting on More Than One Front

March 16th 2022

My heart breaks for patients with cancer and other health conditions who are forced to flee the war-torn Ukraine.

Invading Cancer Cells With Immunotherapy Combinations

March 16th 2022

Recent research has demonstrated the ability of immunotherapy combinations to target advanced melanoma.

Merck Stops Trial After Analysis Reveals Keytruda Plus Lynparza Was Ineffective in Prostate Cancer Treatment

March 16th 2022

In a news release, Merck advised patients enrolled on the trial to consult with their health care provider regarding their treatment.

Cabometyx-Tecentriq Combo Fails to Improve Survival in Patients With Liver Cancer

March 15th 2022

The combination of Cabometyx and Tecentriq failed to improve overall survival in patients with advanced hepatocellular carcinoma, the most common type of primary liver cancer, compared with single-agent Tecentriq or Nexavar.

Male Cancer Caregivers Navigate A Gauntlet of Challenges, Often Under The Cover of Darkness

March 15th 2022

Regardless of a man’s age, providing care to a partner or family member with cancer has been shown to take a drastic toll on their health. To make matters worse, research shows many men struggle in silence.

While Cancer Mutations Are Scary, They Offer Hope for a Better Future

March 15th 2022

I have come to notice striking similarities between the variants of COVID-19 and the countless genetic mutations found in the cancer world, and all I can continue to do is hope for the future.

Record-High Gas Prices ‘Pinching’ the Pockets of Many Patients Traveling Long Distances for Cancer Treatment

March 15th 2022

As the average price of regular-grade gas in the United States speeds past $4.30 a gallon, many patients with cancer may be wondering how they can afford to get to and from cancer treatments. Luckily, there’s assistance to make travel less expensive.

Marathon ‘Streakers’ Say They Won’t Stop Running Until a Cure for Cancer is Found

March 15th 2022

As The DONNA Foundation’s 15th annual marathon brings the breast cancer community together, two “streakers” discuss why they continue to participate in every marathon.

Novel Drug Fails to Improve Survival in a Certain Group of Patients With Breast Cancer

March 14th 2022

Treatment with amcenestrant failed to improve survival when compared with a physician’s choice of a single-agent endocrine therapy in patients with metastatic or locally advanced breast cancer.

Multiple Myeloma is Being Diagnosed More Often in Younger Patients, But The Reasons Why Are Unclear

March 14th 2022

As more and more people in their 20s and 30s begin to receive diagnoses of multiple myeloma, a type of blood cancer, one expert stresses that continued research to improve survival in this patient population is critical.

Cancerphobic: How My Cancer History Put Me on ‘High Alert’ for Potential New Diagnoses

March 14th 2022

When two small spots appeared on my face, I couldn’t help but wonder if they might be cancerous. Had I failed to protect my skin with a hat or sunscreen? Suddenly, I was cancerphobic.

CAR-T Cell Therapies Offer ‘An Opportunity for Majority of Patients’ With Lymphoma to Be Treated

March 14th 2022

Unlike stem cell transplant, which has strict eligibility criteria, the majority of patients with blood cancer may be able to receive CAR-T cell therapy, regardless of other comorbidities, explained an expert.

Cancer Advocacy Helps Ease Nerves and Uncertainty, Says One Patient

March 14th 2022

A patient’s experience with polycythemia vera — a rare blood cancer — led to her becoming an advocate for others to help ease all the nerves and uncertainty that many patients face when they hear they have cancer.

FDA Approves Lynparza for Treatment of Certain Patients With High-Risk, Early-Stage Breast Cancer

March 11th 2022

The FDA’s decision to OK Lynparza is based on data from the OlympiA trial, which showed that Lynparza reduced the risk of invasive breast cancer recurrences, second cancers or death by 42% versus placebo after initial treatment with chemotherapy.

FDA to Fast Track Review of Experimental Drug HPN217 to Treat Relapsed/Refractory Myeloma

March 11th 2022

The FDA plans to speed up its review of HPN217 for the treatment of patients with relapsed, refractory multiple myeloma who have received at least four prior lines of therapy.

Chemotherapy-Induced Peripheral Neuropathy Cannot Be Cured, But There Are Many Ways Patients Can Reduce its Severity

March 11th 2022

The pain and numbness from chemotherapy-induced peripheral neuropathy — commonly referred to as CIPN — can severely impact the lives of patients with cancer, though there are ways that patients can mitigate the intensity or live better with the condition.

It’s You and Not Me: Reasons Why I’m Breaking Up With My Doctor

March 11th 2022

I’ve been feeling like I’m walking on eggshells around my doctor, so I think it’s time that we see other people.

Former ‘Law & Order’ Star Discusses Wife’s Cancer Journey, ‘Sesame Street’ Actor Emilio Delgado Dies From Multiple Myeloma and More

March 11th 2022

From Emilio Delgado, the actor who portrayed Luis on “Sesame Street”, dying from multiple myeloma to actor Benjamin Bratt discussing his wife’s breast cancer journey, here’s what’s happening in the cancer space this week.

Drugs Established for Other Health Conditions May Provide Cancer Benefit

March 11th 2022

Drugs that control blood pressure and lower cholesterol, among others, may help patients derive greater benefit from cancer treatment, but study findings have left researchers reassessing their next moves.

Trial to Assess Safety and Efficacy of Novel Drug for Extremely Rare Cancer Begins Enrolling Patients

March 10th 2022

The rare cancer, known as adenoid cystic carcinoma, is diagnosed in fewer than 1,500 people in the United States each year and is often found in the salivary glands, a part of the body associated with helping a person swallow and digest food.

FDA’s Carvykti Approval Gives Patients Whose Myeloma Has ‘Failed Everything’ Another Chance to Attack the Disease

March 10th 2022

The recent FDA approval of the CAR-T cell therapy Carvykti represents a life-changing advancement for patients with multiple myeloma whose disease progressed after countless other treatments, according to an expert.

Cancer Changed My Relationship With Pain: ‘Being a Trooper’ Is Not Always a Good Thing

March 10th 2022

After seeing my brother go through extraordinary pain because of lymphoma and then surviving breast cancer myself, I always pushed through the pain — even when I shouldn’t have.

Decades' Worth of Reconstruction Advancements Have Transformed the Lives of Many Patients Who Underwent Debilitating Cancer Treatments

March 10th 2022

Aesthetic appearances, according to an expert at the UCSF, are often important for patients following the surgical treatment of cancer. Advancements in this space over the past 20 years have allowed many to patients to look as normal as possible.

FDA's Approval of Besremi Marks 'One of the Most Important Developments' in Treatment of Polycythemia Vera

March 10th 2022

Recently approved, by the Food and Drug Administration, Besremi has demonstrated to be effective and safe for patients with polycythemia vera — adding hope to their treatment regimen.

Combination Maintenance Therapy After Stem Cell Transplant May Prolong Survival in Multiple Myeloma

March 9th 2022

Maintenance therapy with Ninlaro and Revlimid in patients with recently diagnosed multiple myeloma who underwent a stem cell transplant may safely improve survival, although more research is needed especially in high-risk patients.

How a Nutritious Diet May Help During Myeloma Treatment

March 9th 2022

Maintaining a healthy diet during treatment may help combat side effects.

Now That I’m Cancer-Free, I Wonder if I Should be Doing More

March 9th 2022

My osteosarcoma has been under control for a few years now, and in my moments of free time, I start to feel guilty for lacking the drive to take on more.